Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Krell

Showing results (21-30 of 135) with videos related to

Pageof 14
Sort By:
Pharmacogenomics|July 31, 2012
Can pharmacogenomics guide effective anticancer therapy in pancreatic ductal adenocarcinoma?Jonathan Krell, Adam E Frampton, Long R Jiao, et al.
Therapeutic Advances in Medical Oncology|June 12, 2020
Practical guidance for the management of side effects during rucaparib therapy in a multidisciplinary UK settingLaura Tookman, Jonathan Krell, Baleseng Nkolobe, et al.
Molecular and Cellular Biology|August 7, 2013
Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTENAlexander de Giorgio, Jonathan Krell, Victoria Harding, et al.
Pharmacogenomics|April 21, 2012
Highlights from the latest articles in breast cancer pharmacogenomicsJonathan Krell, Adam E Frampton, Ingolf Cascorbi, et al.
Expert Review of Anticancer Therapy|May 19, 2012
Retinoblastoma protein determines aggressiveness in triple-negative breast cancerJimmy Jacob, Adam E Frampton, Leandro Castellano, et al.
Pharmacogenomics|April 21, 2012
miRNAs in breast cancer: ready for real time?Jonathan Krell, Adam E Frampton, Jimmy Jacob, et al.
Bioarchitecture|September 5, 2013
MicroRNA-23b regulates cellular architecture and impairs motogenic and invasive phenotypes during cancer progressionLoredana Pellegrino, Jonathan Krell, Laura Roca-Alonso, et al.
Trends in Microbiology|September 4, 2022
Polymorphic microbes: a new emerging hallmark of cancerMark P Lythgoe, Benjamin H Mullish, Adam E Frampton, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 18, 2013
Optimizing unresectable colorectal liver metastases for surgery--no limits, any benefits?Tamara M H Gall, Adam E Frampton, Jonathan Krell, et al.
Annals of Surgical Oncology|September 2, 2017
A Review of Thoracic and Mediastinal Cytoreductive Techniques in Advanced Ovarian Cancer: Extending the BoundariesSara Nasser, Mara Kyrgiou, Jonathan Krell, et al.
Pageof 14

Showing results (21-30 of 135) with videos related to

Sort By:
Pageof 14
Pharmacogenomics|July 31, 2012
Can pharmacogenomics guide effective anticancer therapy in pancreatic ductal adenocarcinoma?Jonathan Krell, Adam E Frampton, Long R Jiao, et al.
Therapeutic Advances in Medical Oncology|June 12, 2020
Practical guidance for the management of side effects during rucaparib therapy in a multidisciplinary UK settingLaura Tookman, Jonathan Krell, Baleseng Nkolobe, et al.
Molecular and Cellular Biology|August 7, 2013
Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTENAlexander de Giorgio, Jonathan Krell, Victoria Harding, et al.
Pharmacogenomics|April 21, 2012
Highlights from the latest articles in breast cancer pharmacogenomicsJonathan Krell, Adam E Frampton, Ingolf Cascorbi, et al.
Expert Review of Anticancer Therapy|May 19, 2012
Retinoblastoma protein determines aggressiveness in triple-negative breast cancerJimmy Jacob, Adam E Frampton, Leandro Castellano, et al.
Pharmacogenomics|April 21, 2012
miRNAs in breast cancer: ready for real time?Jonathan Krell, Adam E Frampton, Jimmy Jacob, et al.
Bioarchitecture|September 5, 2013
MicroRNA-23b regulates cellular architecture and impairs motogenic and invasive phenotypes during cancer progressionLoredana Pellegrino, Jonathan Krell, Laura Roca-Alonso, et al.
Trends in Microbiology|September 4, 2022
Polymorphic microbes: a new emerging hallmark of cancerMark P Lythgoe, Benjamin H Mullish, Adam E Frampton, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 18, 2013
Optimizing unresectable colorectal liver metastases for surgery--no limits, any benefits?Tamara M H Gall, Adam E Frampton, Jonathan Krell, et al.
Annals of Surgical Oncology|September 2, 2017
A Review of Thoracic and Mediastinal Cytoreductive Techniques in Advanced Ovarian Cancer: Extending the BoundariesSara Nasser, Mara Kyrgiou, Jonathan Krell, et al.
Pageof 14